Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting CompoundsEwgenij Proschak, Daniel Merk, Holger Stark|Journal of Medicinal Chemistry|2018Cited by 476
DOGS: Reaction-Driven de novo Design of Bioactive CompoundsMarkus Hartenfeller, Gisbert Schneider, Heiko Zettl et al.|PLoS Computational Biology|2012Cited by 264
Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant BacteriaFranca‐Maria Klingler, Ewgenij Proschak, Arno Koenigs et al.|Journal of Medicinal Chemistry|2015Cited by 152
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ ModulationSilvia Arifi, Daniel Merk, Julian A. Marschner et al.|Journal of the American Chemical Society|2023Cited by 49
<scp>l</scp>-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγLeonie Gellrich, Daniel Merk, Pascal Heitel et al.|Journal of Medicinal Chemistry|2020Cited by 49